{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:51:05Z","timestamp":1794433865665,"version":"4.9.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007950","name":"Tanta University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007950","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hypoxic-ischemic encephalopathy (HIE) is one of the major complications that can lead to death or disability in neonates. We assessed the effect of citicoline as a neuroprotector in neonates with moderate and severe HIE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This clinical trial was carried on 80 neonates with moderate to severe HIE who were not candidates for therapeutic cooling. They were subdivided randomly into two groups; citicoline treatment group which included 40 neonates who received citicoline 10\u00a0mg \/ kg \/12\u00a0h IV for 4\u00a0weeks plus other supportive measures and the control group which included 40 neonates who were managed with placebo and the same supportive measures. All patients were evaluated for duration of mechanical ventilation (MV), need for inotropes, seizures (type, frequency, and duration), and duration of NICU. Cranial ultrasounds and brain magnetic resonance image (MRI) were performed for all included neonates after 4\u00a0weeks of treatment. Follow- ups of all neonates for the neurodevelopmental outcomes were done at 3, 6, 9, and 12\u00a0months.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There was a significant reduction in the number of neonates having seizures after discharge in the citicoline-treated group (2 neonates) compared to the control group (11 neonates). Cranial ultrasound and MRI findings at 4\u00a0weeks were significantly better in the treatment group compared to the control group. Moreover, neurodevelopmental outcome showed significant improvement at 9 and 12\u00a0months in the citicoline treated neonates compared to the control group. There was statistically significant reduction in the duration of seizures, NICU stay, inotrope use, and MV in the treatment group compared to the control group. Citicoline was well tolerated with no remarkable side effects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Citicoline could be a promising neuroprotector drug in neonates with HIE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The study was registered at ClinicalTrials.gov (NCT03949049). Registered at 14 May 2019, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03949049\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03949049<\/jats:ext-link><\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13052-023-01452-5","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T15:02:10Z","timestamp":1683903730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Citicoline in hypoxic ischemic encephalopathy in neonates: a randomized controlled trial"],"prefix":"10.1186","volume":"49","author":[{"given":"Abeer","family":"Salamah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7836-1170","authenticated-orcid":false,"given":"Doaa","family":"El Amrousy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Elsheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Mehrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,12]]},"reference":[{"issue":"3","key":"1452_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1053\/j.nainr.2011.07.004","volume":"11","author":"KA Allen","year":"2011","unstructured":"Allen KA, Brandon DH. hypoxic ischemic encephalopathy: pathophysiology and experimental treatments newborn. Infant Nurs Rev. 2011;11(3):125\u201333.","journal-title":"Infant Nurs Rev"},{"issue":"6","key":"1452_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.earlhumdev.2010.05.010","volume":"86","author":"JJ Kurinczuk","year":"2010","unstructured":"Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev. 2010;86(6):329\u201338.","journal-title":"Early Hum Dev"},{"key":"1452_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/609813","volume":"2011","author":"M Lai","year":"2011","unstructured":"Lai M, Yang S. Perinatal hypoxic-ischemic encephalopathy. J Biomed Biotechnol. 2011;2011: 609813.","journal-title":"J Biomed Biotechnol"},{"issue":"11","key":"1452_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142424","volume":"10","author":"O Arteaga","year":"2015","unstructured":"Arteaga O, Revuelta M, Urig\u00fcen L, \u00c1lvarez A, Montalvo H, Hilario E. Pretreatment with resveratrol prevents neuronal injury and cognitive deficits induced by perinatal hypoxia-ischemia in rats. PLoS ONE. 2015;10(11): e0142424.","journal-title":"PLoS ONE"},{"key":"1452_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fnmol.2019.00088","volume":"12","author":"X Qin","year":"2019","unstructured":"Qin X, Cheng J, Zhong Y, Mahgoub OK, Akter F, Fan Y, Aldughaim M, Xie Q, Qin L, Gu L, Jian Z, Xiong X, Liu R. Mechanism and treatment related to oxidative stress in neonatal hypoxic-ischemic encephalopathy. Front Mol Neurosci. 2019;12:88.","journal-title":"Front Mol Neurosci"},{"issue":"11","key":"1452_CR6","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2174\/1381612820999141029162457","volume":"21","author":"T Zalewska","year":"2015","unstructured":"Zalewska T, Jaworska J, Ziemka-Nalecz M. Current and experimental pharmacological approaches in neonatal hypoxic- ischemic encephalopathy. Curr Pharm Des. 2015;21(11):1433\u20139.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"1452_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pedneo.2015.04.008","volume":"57","author":"MC Chiang","year":"2016","unstructured":"Chiang MC, Lien R, Chu SM, Yang PH, Lin JJ, Hsu JF, Fu RH, Lin KL. Serum lactate, brain magnetic resonance imaging and outcome of neonatal hypoxic ischemic encephalopathy after therapeutic hypothermia. Pediatr Neonatol. 2016;57(1):35\u201340.","journal-title":"Pediatr Neonatol"},{"issue":"4","key":"1452_CR8","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00431-020-03871-6","volume":"180","author":"A Salamah","year":"2021","unstructured":"Salamah A, Mehrez M, Faheem A, El Amrousy D. Efficacy of citicoline as a neuroprotector in children with post cardiac arrest: a randomized controlled clinical trial. Eur J Pediatr. 2021;180(4):1249\u201355.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"1452_CR9","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3390\/brainsci3031395","volume":"3","author":"J \u00c1lvarez-Sab\u00edn","year":"2013","unstructured":"\u00c1lvarez-Sab\u00edn J, Rom\u00e1n GC. The role of citicoline in neuroprotection and neurorepair in ischemic stroke. Brain Sci. 2013;3(3):1395\u2013414.","journal-title":"Brain Sci"},{"key":"1452_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/1874143620130805001","volume":"7","author":"A Hobson","year":"2013","unstructured":"Hobson A, Baines J, Weiss MD. Beyond hypothermia: alternative therapies for hypoxic ischemic encephalopathy. Open Pharm J. 2013;7:26\u201340.","journal-title":"Open Pharm J"},{"key":"1452_CR11","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1001\/archneur.1976.00500100030012","volume":"33","author":"HB Sarnat","year":"1976","unstructured":"Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. a clinical and electroencephalographic study.\u00a0 Arch Neurol. 1976;33:696\u2013705.","journal-title":"Arch Neurol"},{"issue":"6","key":"1452_CR12","first-page":"11","volume":"2","author":"I Qureshi","year":"2010","unstructured":"Qureshi I, Endres JR. Citicoline: a novel therapeutic agent with neuroprotective, neuromodulatory, and neuroregenerative properties. Natural Medicine J. 2010;2(6):11\u201325.","journal-title":"Natural Medicine J"},{"key":"1452_CR13","first-page":"11","volume":"3","author":"K Abdulqawi","year":"2011","unstructured":"Abdulqawi K, Al-Zohairy YZ, Karam K. Early predictors of neurodevelopmental adverse outcome in term infants with post asphyxial hypoxic ischemic encephalopathy. Int J Collab Res Intern Med Public. 2011;3:11.","journal-title":"Int J Collab Res Intern Med Public"},{"key":"1452_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/adc.87.2.109","volume":"87","author":"J Ivens","year":"2002","unstructured":"Ivens J, Martin N. A common metric for the Griffiths Scales. Arch Dis Child. 2002;87:109\u201310.","journal-title":"Arch Dis Child"},{"key":"1452_CR15","first-page":"S1","volume":"52","author":"JJ Secades","year":"2011","unstructured":"Secades JJ. Citicoline: pharmacological and clinical review. Rev Neurol. 2011;52:S1-62.","journal-title":"Rev Neurol"},{"issue":"1","key":"1452_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5409\/wjcp.v5.i1.67","volume":"5","author":"CE Ahearne","year":"2016","unstructured":"Ahearne CE, Boylan GB, Murray DM. Short and long term prognosis in perinatal asphyxia: an update. World J Clin Pediatr. 2016;5(1):67\u201374.","journal-title":"World J Clin Pediatr"},{"issue":"12","key":"1452_CR17","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.29271\/jcpsp.2021.12.1511","volume":"31","author":"A Khushdil","year":"2021","unstructured":"Khushdil A, Ahmed Z, Ehsan A. Role of citicoline in treatment of moderate to severe birth asphyxia: a Pilot Project. J Coll Physicians Surg Pak. 2021;31(12):1511\u20132.","journal-title":"J Coll Physicians Surg Pak"},{"key":"1452_CR18","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1161\/01.STR.0000038691.03334.71","volume":"33","author":"A Davalos","year":"2002","unstructured":"Davalos A, Castillo J, Alvarez-Sabin J, Secades JJ, Mercadal J, L\u00f3pez S, Cobo E, Warach S, Sherman D, Clark WM, Lozano R. Oral citicoline in acute ischemic stroke. Stroke. 2002;33:2850\u20137.","journal-title":"Stroke"},{"issue":"3","key":"1452_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10517-015-2750-y","volume":"158","author":"MN Karpova","year":"2015","unstructured":"Karpova MN, Zin\u2019kovskii KA, Kuznetsova LV, Klishina NV. Increase of the seizure threshold in C57BL\/6 mice after citicoline injection. Bull Exp Biol Med. 2015;158(3):315\u20137.","journal-title":"Bull Exp Biol Med"},{"issue":"4","key":"1452_CR20","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10517-016-3188-6","volume":"160","author":"MN Karpova","year":"2016","unstructured":"Karpova MN, Kuznetsova LV, Zin\u2019kovskii KA, Klishina NV. Anticonvulsant effects of combined treatment with citicoline and valproate on the model of acute generalized convulsions induced by pentylenetetrazole in wistar rats. Bull Exp Biol Med. 2016;160(4):429\u201331.","journal-title":"Bull Exp Biol Med"},{"key":"1452_CR21","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1682\/JRRD.2008.09.0120","volume":"46","author":"E Chew","year":"2009","unstructured":"Chew E, Zafonte RD. Pharmacological management of neurobehavioral disorders following traumatic brain injury\u2013a state-of-the-art review. J Rehabil Res Dev. 2009;46:851\u201379.","journal-title":"J Rehabil Res Dev"},{"key":"1452_CR22","first-page":"167","volume":"5","author":"JL Saver","year":"2008","unstructured":"Saver JL. Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair. Rev Neurol Dis. 2008;5:167\u201377.","journal-title":"Rev Neurol Dis"},{"issue":"7","key":"1452_CR23","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.01.020","volume":"23","author":"K Overgaard","year":"2014","unstructured":"Overgaard K. The effects of citicoline on acute ischemic stroke: a review. J Stroke Cerebrovasc Dis. 2014;23(7):1764\u20139.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1 Suppl","key":"1452_CR24","first-page":"S33","volume":"42","author":"O Hurtado","year":"2011","unstructured":"Hurtado O, Lizasoain I, Moro M\u00c1. Neuroprotection and recovery: recent data at the bench on citicoline. Stroke. 2011;42(1 Suppl):S33\u20135.","journal-title":"Stroke"},{"key":"1452_CR25","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1089\/neu.2008.0794","volume":"26","author":"S Margulies","year":"2009","unstructured":"Margulies S, Hicks R. Combination therapies for traumatic brain injury: prospective considerations. J Neurotrauma. 2009;26:925\u201339.","journal-title":"J Neurotrauma"},{"issue":"6","key":"1452_CR26","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1179\/016164110X12807570510176","volume":"33","author":"T Sobrino","year":"2011","unstructured":"Sobrino T, Rodr\u00edguez-Gonz\u00e1lez R, Blanco M, Brea D, P\u00e9rez-Mato M, Rodr\u00edguez-Y\u00e1\u00f1ez M, Leira R, Castillo J. CDP-choline treatment increases circulating endothelial progenitor cells in acute ischemic stroke. Neurol Res. 2011;33(6):572\u20137.","journal-title":"Neurol Res"},{"key":"1452_CR27","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1161\/STROKEAHA.112.654806","volume":"43","author":"K Diederich","year":"2012","unstructured":"Diederich K, Frauenknecht K, Minnerup J, Schneider BK, Schmidt A, Altach E, Eggert V, Sommer CJ, Sch\u00e4bitz WR. Citicoline enhances neuroregenerative process after experimental stroke in rats. Stroke. 2012;43:1931\u201340.","journal-title":"Stroke"},{"key":"1452_CR28","first-page":"1","volume":"28","author":"JJ Secadesm","year":"2006","unstructured":"Secadesm JJ, Lorenzo JL. Citicoline: pharmacological and clinical review. Clin Pharmacol. 2006;28:1\u201356.","journal-title":"Clin Pharmacol"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-023-01452-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-023-01452-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-023-01452-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T15:07:08Z","timestamp":1683904028000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-023-01452-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1452"],"URL":"https:\/\/doi.org\/10.1186\/s13052-023-01452-5","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,12]]},"assertion":[{"value":"30 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Local ethics committee of Faculty of Medicine, Tanta University approved the study. The study is in accordance with the ethical standards of institutional research committee and with the 1964 Helsinki declaration and its later amendments. Written informed consent was obtained from the parents of all subjects of the study before enrolment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.Clinical trial registration: The study was registered at ClinicalTrials.gov (NCT03949049).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}